• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation

    3/17/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care
    Get the next $KIDS alert in real time by email

    WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company's cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.​

    The Crossroads Pediatric Device Consortium is a multi-institutional initiative focused on accelerating the development, approval, and availability of medical devices designed specifically for pediatric patients. Founding members include Purdue University's Weldon School of Biomedical Engineering, the Indiana University School of Medicine's Department of Pediatrics, and Cook Medical, a leader in medical device manufacturing. OrthoPediatrics' addition to the consortium brings specialized expertise in pediatric orthopedics, further strengthening the consortium's capabilities to develop and commercialize pediatric medical devices.

    "We are proud to join the Crossroads Pediatric Device Consortium, as it aligns with our cause of advancing healthcare for KIDS all over the world," said David Bailey, President & CEO of OrthoPediatrics. "By collaborating with CPDC's network of experts, we aim to drive innovation in pediatric medical technology and ensure children have access to the specialized treatments they need."​

    Matthew Waninger, Managing Director of Crossroads Pediatric Device Consortium, welcomed the partnership, stating: "OrthoPediatrics has been a leader in pediatric orthopedics for years, and we are thrilled to have them as part of our consortium. Their expertise and dedication to pediatric innovation will be invaluable as we work to accelerate the development and accessibility of breakthrough medical devices for children."​

    With OrthoPediatrics joining, the Crossroads Pediatric Device Consortium strengthens its industry partnerships through a distinctive model that directly integrates major medical device companies. By integrating industry leaders into its network, the consortium streamlines product development, regulatory navigation, and commercialization, ensuring pediatric medical innovations move efficiently from concept to market.

    About OrthoPediatrics Corp.

    Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 75 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics' global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.

    About Crossroads Pediatric Device Consortium (CPDC)

    The Crossroads Pediatric Device Consortium is a collaborative initiative between Purdue University's Weldon School of Biomedical Engineering, the Indiana University School of Medicine's Department of Pediatrics, and Cook Medical. Crossroads Pediatric Device Consortium aims to bridge the gap between research, clinical needs, and industry by fostering partnerships that accelerate the development, approval, and commercialization of pediatric medical devices.

    Investor Contact

    Philip Trip Taylor

    Gilmartin Group

    [email protected]

    415-937-5406



    Primary Logo

    Get the next $KIDS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KIDS

    DatePrice TargetRatingAnalyst
    4/7/2025$37.00Buy
    Lake Street
    1/25/2024$39.00 → $31.00Buy → Hold
    Truist
    3/3/2022$83.00 → $65.00Buy
    Needham
    12/22/2021$75.00 → $68.00Buy
    BTIG
    12/21/2021$78.00 → $75.00Buy
    Truist Securities
    8/6/2021$70.00 → $77.00Market Outperform
    JMP Securities
    More analyst ratings

    $KIDS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO and CFO Hite Fred bought $98,525 worth of shares (5,076 units at $19.41), increasing direct ownership by 2% to 213,065 units (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    8/25/25 10:24:55 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    Director Hughes Bryan W was granted 8,401 shares, increasing direct ownership by 65% to 21,227 units (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    5/28/25 9:02:07 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    Director Infante (Reynolds) Marie C was granted 8,401 shares, increasing direct ownership by 74% to 19,766 units (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    5/28/25 9:00:19 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System

    WARSAW, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the first U.S. surgical procedures with the VerteGlide Spinal Growth Guidance System ("VerteGlide"), used to treat Early Onset Scoliosis ("EOS"). Dr. Richard McCarthy, a pediatric orthopedic spine surgeon in Louisville, Kentucky who, along with Dr. Kent Walker, performed one of the first procedures shared, "The first procedures with VerteGlide were a great success. For these patients, there is a very limited set of options, and this breakthrough growth

    9/10/25 7:00:00 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.

    WARSAW, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics announced today a new distribution partnership with MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries. This collaboration will expand access to MY01's Continuous Perfusion Sensing Technology™ (CPST™) Platform for children and adolescents, a population at great risk for acute compartment syndrome. Acute compartment syndrome is a time-sensitive emergency that disproportionately affects children with a floating elbow1, tibial2 and forearm3 fractures, and other ort

    9/5/25 7:00:00 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors

    WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025. "We're excited to welcome Kelly Fischer to the OrthoPediatrics Board of Directors. Her proven expertise in financial leadership at Cook Medical will be a significant asset as we execute our strategy and expand our

    8/25/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO and CFO Hite Fred bought $98,525 worth of shares (5,076 units at $19.41), increasing direct ownership by 2% to 213,065 units (SEC Form 4)

    4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

    8/25/25 10:24:55 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    SEC Filings

    View All

    OrthoPediatrics Corp. filed SEC Form 8-K: Leadership Update

    8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)

    8/11/25 3:34:38 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by OrthoPediatrics Corp.

    10-Q - ORTHOPEDIATRICS CORP (0001425450) (Filer)

    8/6/25 3:25:16 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)

    8/5/25 4:33:16 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on OrthoPediatrics with a new price target

    Lake Street initiated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $37.00

    4/7/25 8:25:17 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics downgraded by Truist with a new price target

    Truist downgraded OrthoPediatrics from Buy to Hold and set a new price target of $31.00 from $39.00 previously

    1/25/24 7:05:43 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    Needham reiterated coverage on OrthoPediatrics with a new price target

    Needham reiterated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $65.00 from $83.00 previously

    3/3/22 11:28:34 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Leadership Updates

    Live Leadership Updates

    View All

    OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors

    WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025. "We're excited to welcome Kelly Fischer to the OrthoPediatrics Board of Directors. Her proven expertise in financial leadership at Cook Medical will be a significant asset as we execute our strategy and expand our

    8/25/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation

    WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company's cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.​ The Crossroads Pediatric Device Consortium is a multi-institutional initiative focused on accelerating the development, approval, and availability of medical devices designed specifically for pediatric patients. Founding member

    3/17/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Joins Alliance for Pediatric Device Innovation

    WARSAW, Ind., Oct. 12, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, has announced a strategic partnership with Children's National Hospital in Washington, DC under the "Alliance for Pediatric Device Innovation" (APDI), to advice the development and commercialization of medical devices designed for children. Along with Children's National, APDI consortium members include Johns Hopkins University, CIMIT at Mass General Brigham, Tufts Medical Center and Medstar Health Research Institute. The Company will serve as APDI's strategic advisor and role model for devic

    10/12/23 8:05:00 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Financials

    Live finance-specific insights

    View All

    OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance

    WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 and Business Highlights       Helped over 37,000 children in the second quarter of 2025Generated new record high total revenue of $61.1 million for the second quarter of 2025, up 16% from $52.8 million in second quarter 2024; domestic revenue increased 17% and international revenue increased 12% in the quarterGrew worldwide Trauma & Deformity revenue 10% and worldwide Scoliosis revenue 35%

    8/5/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025

    WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2025 financial results on August 5, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 5, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for

    7/22/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance

    WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 and Business Highlights Helped a record of nearly 39,000 children in the first quarter of 2025Generated total revenue of $52.4 million for the first quarter of 2025, up 17% from $44.7 million in first quarter 2024; domestic revenue increased 19% and international revenue increased 11% in the quarterGrew worldwide Trauma & Deformity revenue 14% and worldwide Scoliosis revenue 34% in the first

    5/7/25 4:05:00 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    $KIDS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by OrthoPediatrics Corp.

    SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    11/14/24 1:34:08 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by OrthoPediatrics Corp. (Amendment)

    SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    5/8/24 2:22:57 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by OrthoPediatrics Corp. (Amendment)

    SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

    2/14/24 3:33:43 PM ET
    $KIDS
    Medical/Dental Instruments
    Health Care